Effect of Artronat on the Quality of Life of Patient With Osteoarthritis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01356199|
Recruitment Status : Completed
First Posted : May 19, 2011
Last Update Posted : March 18, 2014
|Condition or disease||Intervention/treatment|
|Osteoarthritis||Dietary Supplement: ARTRONAT Dietary Supplement: PLACEBO|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||7 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Triple (Participant, Care Provider, Investigator)|
|Primary Purpose:||Supportive Care|
|Official Title:||Effet du complément Alimentaire ARTRONAT(R) Sur la réduction de la Gonalgie Chez Des Sujets Arthrosiques|
|Study Start Date :||October 2011|
|Primary Completion Date :||January 2013|
|Study Completion Date :||December 2013|
Dietary Supplement: ARTRONAT
Dietary supplement containing Glucosamine, Chondroïtine and manganese. 6 per day for 8 months.
|Placebo Comparator: PLACEBO||
Dietary Supplement: PLACEBO
PLACEBO. 6 per day for 8 months.
- Reduction of gonalgia [ Time Frame: T8 months ]measure with the WOMAC.
- Evaluation of the satisfactory relief of symptoms of osteoarthritis at each visit after the beginning of supplementation, assessed by the patients. [ Time Frame: T2, T4, T6, T8 months ]Subjective global assessment measured on a 10-cm graduated scale (Visual Analogue Scale)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01356199
|Centre Rééducation et Réadaptation Fonctionnelles de Trestel , Centre Hospitalier Pierre-Le-Damany Lannion|
|Treviou Treguignec, France, 22660|
|Study Chair:||Maurice Cloarec, MD||Association Nationale de Prevention Medicale|
|Principal Investigator:||Dominique Baron, MD||Hospital Center of Lanion|